Meeting The Chiral Challenge - C&EN Global ... - ACS Publications

Advertisements that appeared within the print issues of Chem. Eng. News have been included in the C&EN Archives to provide a comprehensive representat...
0 downloads 0 Views 260KB Size
Celgaie

Meeting The Chiral Challenge

The path to drug commercialization is always difficult and often riskyeven more so if it involves a chiral molecule. Celgene's extensive experience and recognized excellence with chiral chemical manufacturing can help you meet your goals. Our integrated biocatalysis and chemistry R&D will get you started on the right foot. For biocatalytic processes, our proprietary MODIZYME™ enzyme tailoring technology will enable us to make improvements in biocatalyst performance as the need develops. Celgene's chiral production capabilities can keep pace with you as your project moves from preclinical quantities to full GMP commercial manufacturing. For information o n how Celgene can help you reach your chiral drug development goals, contact: Linda Dell, Account Manager, Chiral Pharmaceuticals Group (908) 271-4192 (voice) or (908) 271-4184 (Fax). Celgene Corporation 7 Powder Horn Drive Warren, NJ 07059 USA

CIRCLE 4 0 ON READER SERVICE CARD